Author:
Van Hattum J. W.,Scutigliani E. M.,Helderman R. F. C. P. A.,Zweije R.,Rodermond H. M.,Oei A. L.,Crezee J.,Oddens J. R.,De Reijke T. M.,Krawczyk P. M.
Abstract
AbstractHyperthermic intravesical chemotherapy (HIVEC)—whereby the bladder is heated to ± 43 °C during a chemotherapy instillation—can improve outcomes of non-muscle invasive bladder cancer (NMIBC) treatments. Experiments in animal models are required to explore new hyperthermia based treatments. Existing HIVEC devices are not suitable for rodents or large-scale animal trials. We present a HIVEC setup compatible with orthotopic rat models. An externally heated chemotherapeutic solution is circulated in the bladder through a double-lumen catheter with flow rates controlled using a peristaltic pump. Temperature sensors in the inflow channel, bladder and outflow channel allow temperature monitoring and adjustments in real-time. At a constant flow rate of 2.5 mL/min the system rapidly reaches the desired bladder temperature of 42–43 °C with minimal variability throughout a one-hour treatment in a rat bladder phantom, as well as in euthanised and live rats. Mean intraluminal bladder temperatures were 42.92 °C (SD = 0.15 °C), 42.45 °C (SD = 0.37 °C) and 42.52 °C (SD = 0.09 °C) in the bladder phantom, euthanised, and live rats respectively. Thermal camera measurements showed homogenous heat distributions over the bladder wall. The setup provides well-controlled thermal dose and the upscaling needed for performing large scale HIVEC experiments in rats.
Publisher
Springer Science and Business Media LLC
Reference51 articles.
1. Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68, 394–424 (2018).
2. EAU Guidelines: Non-muscle-invasive Bladder Cancer | Uroweb. https://uroweb.org/guideline/non-muscle-invasive-bladder-cancer/#11.
3. Rj, S. et al. European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) incorporating the WHO 2004/2016 and WHO 1973 classification systems for grade: An update from the EAU NMIBC guidelines panel. Eur. Urol. 79, 480–488 (2021).
4. Nederlandse Kankerregistratie (NKR), IKNL. www.iknl.nl/nkr-cijfers.
5. Porter, M. P., Gore, J. L. & Wright, J. L. Hospital volume and 90-day mortality risk after radical cystectomy: A population-based cohort study. World J. Urol. 29, 73–77 (2011).
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献